Physician

Ahmed Mahros Kamal Baiomi, MD

According to 2025 Medicare claims, Ahmed Baiomi, MD (NPI: 1922414226) practices gastroenterology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1669770004; TIN: 23-2730785) and primary practice location at 17403-3676. Baiomi is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Baiomi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 319 traditional Medicare patients, billed 476 HCPCS/CPT codes, and received $48,503 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 527 prescription claims across 128 beneficiaries totaling $170,217 in drug costs, led by Creon (Lipase/Protease/Amylase). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $24,242 to $170,217. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$26K$51K2021 Medicare payment: $17,037 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $42,200 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $51,192 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $48,503 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021117163$17,037
2022308449$42,200
2023320493$51,192
2024319476$48,503

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$85K$170K2015 Drug cost: $24,242 (USD; Tot_Drug_Cst)2016 Drug cost: $26,980 (USD; Tot_Drug_Cst)2017 Drug cost: $11,237 (USD; Tot_Drug_Cst)2018 Drug cost: $873 (USD; Tot_Drug_Cst)2019 Drug cost: $17,358 (USD; Tot_Drug_Cst)2020 Drug cost: $10,726 (USD; Tot_Drug_Cst)2021 Drug cost: $18,310 (USD; Tot_Drug_Cst)2022 Drug cost: $36,553 (USD; Tot_Drug_Cst)2023 Drug cost: $94,581 (USD; Tot_Drug_Cst)2024 Drug cost: $170,217 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563370$24,242
201652433$26,980
201720136$11,237
20182142$873
20194788$17,358
202054101$10,726
202164148$18,310
2022108347$36,553
2023127445$94,581
2024128527$170,217

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare6969$187
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes7779$98
45380Biopsy of large bowel using a flexible endoscope6262$86
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope5152$69
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes5162$59

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CreonLipase/Protease/Amylase24537$36,201
LinzessLinaclotide18540$13,749
Pantoprazole SodiumPantoprazole Sodium22411,661$1,756
Budesonide DrBudesonide12370$1,338
OmeprazoleOmeprazole493,810$1,184

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Ahmed Mahros Kamal Baiomi, MD?

Tedicare shows public-source Medicare data for Ahmed Mahros Kamal Baiomi, MD (NPI 1922414226), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Mahros Kamal Baiomi, MD have ACO affiliation data?

Ahmed Mahros Kamal Baiomi, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Ahmed Mahros Kamal Baiomi, MD?

Ahmed Mahros Kamal Baiomi, MD is linked to WELLSPAN MEDICAL GROUP (billing NPI 1669770004) in the available physician profile data.

Does Ahmed Mahros Kamal Baiomi, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.